Analysis of clinical distribution and drug resistance of <i>Escherichia coli </i> and <i>Klebsiella pneumoniae</i> in a hospital of Nanjing from 2020 to 2022

Journal Title: Chinese Journal of Clinical Research - Year 2024, Vol 37, Issue 5

Abstract

<b>Objective</b> The clinical distribution and drug resistance of <i>Escherichia coli </i> and<i>Klebsiella pneumoniae </i> in a hospital of Nanjing from 2020 to 2022 were analyzed in order to provide the basis for clinical rational use of antibiotics. <b>Methods</b> The distribution and drug resistance of <i>Escherichia coli </i> and <i>Klebsiella pneumoniae </i> specimens in Zhongda Hospital Southeast University from 2020 to 2022 were retrospectively analyzed.<b>Results</b> A total of 3 507, 4 323 and 4 806 pathogenic bacteria were detected from 2020 to 2022. There were 616, 748 and 840 strains of <i>Escherichia coli </i>, and 456, 631 and 757 strains of <i>Klebsiella pneumoniae </i>, with the total 3-year detection rate of 17.4% and 14.6%. There was a statistically significant difference in the constituent ratio of pathogenic bacteria between 2020 and 2022 (P<0.01). From 2020 to 2022, the top three samples of pathogenic bacteria were sputum, blood and urine. From 2020 to 2022, the drug resistance rates of <i>Escherichia coli </i> to cefepime, ceftriaxone, cefazolin, gentamicin, ciprofloxacin, levofloxacin and compound trimethoprim were significantly different (P<0.01). The drug resistance rates of <i>Klebsiella pneumoniae </i> to imipenem, ertapenem, cefepime, ceftriaxone, cefoperazone sulbactam, cefazolin, cefoxitin, piperacillin tazobactam, ampicillin, amikacin, gentamicin, levofloxacin, nitrofurantoin and compound trimethoprim were significantly different (P<0.01).<b>Conclusion</b> The average detection rate of <i>Escherichia coli </i>and <i>Klebsiella pneumoniae </i> was more than 30% in 2020—2022. The resistance of <i>Escherichia coli </i>and <i>Klebsiella pneumoniae </i> to various antibacterial drugs is statistically different. The clinically targeted drugs need to be selected in strict accordance with the drug sensitivity results.

Authors and Affiliations

ZHANG Hongfang, LU Jin, CHEN Zhicheng, HU Jimei, KONG Qingfang

Keywords

Related Articles

Progress of perfusion related problems and nursing in flexible ureteroscopic lithotripsy

Flexible ureteroscopic lithotripsy is the main minimally invasive surgery in the treatment of ureteral calculi, with many advantages such as little trauma, short hospitalization time and low surgical risk. However, a lar...

Correlation between serum manganese and non-alcoholic fatty liver disease

Objective To investigate the relationship between serum manganese (Mn) levels and non-alcoholic fatty liver disease (NAFLD) in individuals of different genders. Methods Participants aged 18 years or older from the Nation...

Predictive value of dynamic assessment of thrombose-related factors in diabetic nephropathy patients for thrombotic risk

"<b>Methods</b> A retrospective study was conducted to select 98 patients with DN who were treated in Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine from January 2020 to September 2022. Follow-u...

Effects of remimazolam combined with mivacurium on recovery quality of patients after vocal cord polypectomy

"<b>Objective</b> To evaluate the effects of remimazolam versus propofol on the quality of postoperative recovery in patients undergoing vocal cord polypectomy with supportive laryngoscopy by the 15-item quality of reco...

Evaluation of the influence of atlantoaxial transverse ligament on stability of atlantoaxial complex fracture using 3D finite element method

<b>Objective</b> To analyze and compare the effects of transverse ligament injury on the stability and stress distribution of atlantoaxial complex fractures using 3D finite element method. <b>Methods</b> A male volunte...

Download PDF file
  • EP ID EP736345
  • DOI 10.13429/j.cnki.cjcr.2024.05.025
  • Views 37
  • Downloads 0

How To Cite

ZHANG Hongfang, LU Jin, CHEN Zhicheng, HU Jimei, KONG Qingfang (2024). Analysis of clinical distribution and drug resistance of <i>Escherichia coli </i> and <i>Klebsiella pneumoniae</i> in a hospital of Nanjing from 2020 to 2022. Chinese Journal of Clinical Research, 37(5), -. https://europub.co.uk/articles/-A-736345